Summary Company Announcement Date: January 09, 2026 FDA Publish Date: January 09, 2026 Product Type: Dietary SupplementsDrugs Reason for Announcement: Recall Reason Description Unapproved new drug […]

Summary Company Announcement Date: January 07, 2026 FDA Publish Date: January 09, 2026 Product Type: Dietary SupplementsDrugs Reason for Announcement: Recall Reason Description Unapproved new drug […]

[embedded content] FDA protects public health by promoting supply chain integrity and working to ensure medicines imported to the U.S. comply with applicable legal and regulatory […]

FDA is aware of news reports of devastating, ongoing diethylene glycol (DEG) and ethylene glycol (EG) contamination in children’s cough and cold medicine in India. FDA […]

Docket Number: FDA-2025-D-3217 Issued by: Guidance Issuing Office Center for Biologics Evaluation and Research Center for Drug Evaluation and Research This draft guidance provides guidance to […]

For Immediate Release: May 22, 2023 Español Today, the U.S. Food and Drug Administration approved Opvee, the first nalmefene hydrochloride nasal spray for the emergency treatment […]

For Immediate Release: March 29, 2023 Español Today, the U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), […]

Summary Company Announcement Date: September 20, 2024 FDA Publish Date: September 23, 2024 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to Presence of […]

Date: November 19 – 20, 2025 Time: 8:30 a.m. – 5:00 p.m. ET Location: Event Location The Universities at Shady GroveBuilding II 9630 Gudelsky DriveRockville, MD […]